{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:47:55Z","timestamp":1779277675305,"version":"3.51.4"},"reference-count":143,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Cystic fibrosis (CF) is one of the most common progressive life-shortening genetic conditions worldwide. Ground-breaking translational research has generated therapies that target the primary cystic fibrosis transmembrane conductance regulator (CFTR) defect, known as CFTR modulators. A crucial aspect of paediatric CF disease is the development and progression of irreversible respiratory disease in the absence of clinical symptoms. Accurate thoracic diagnostics have an important role to play in this regard. Chest radiographs are non-specific and insensitive in the context of subtle changes in early CF disease, with computed tomography (CT) providing increased sensitivity. Recent advancements in imaging hardware and software have allowed thoracic CTs to be acquired in paediatric patients at radiation doses approaching that of a chest radiograph. CFTR modulators slow the progression of CF, reduce the frequency of exacerbations and extend life expectancy. In conjunction with advances in CT imaging techniques, low-dose thorax CT will establish a central position in the routine care of children with CF. International guidelines regarding the choice of modality and timing of thoracic imaging in children with CF are lagging behind these rapid technological advances. The continued progress of personalised medicine in the form of CFTR modulators will promote the emergence of personalised radiological diagnostics.<\/jats:p>","DOI":"10.3390\/children11020256","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T10:40:15Z","timestamp":1708339215000},"page":"256","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Paediatric Thoracic Imaging in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulation"],"prefix":"10.3390","volume":"11","author":[{"given":"Patrick W.","family":"O\u2019Regan","sequence":"first","affiliation":[{"name":"Department of Radiology, Cork University Hospital, T12 DC4A Cork, Ireland"},{"name":"Department of Radiology, School of Medicine, University College Cork, T12 AK54 Cork, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh E.","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mercy University Hospital, T12 WE28 Cork, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh","family":"Logan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mercy University Hospital, T12 WE28 Cork, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cork University Hospital, T12 DC4A Cork, Ireland"},{"name":"Department of Radiology, School of Medicine, University College Cork, T12 AK54 Cork, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Maher","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cork University Hospital, T12 DC4A Cork, Ireland"},{"name":"Department of Radiology, School of Medicine, University College Cork, T12 AK54 Cork, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: The 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Scotet, V., L\u2019Hostis, C., and Ferec, C. (2020). The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery. Genes, 11.","DOI":"10.3390\/genes11060589"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"Cystic Fibrosis of the Pancreas and its Relation to Celiac Disease: A Clinical and Pathologic Study","volume":"56","author":"Andersen","year":"1938","journal-title":"Am. J. Dis. Child."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1378\/chest.11-1972","article-title":"Radiologic imaging in cystic fibrosis: Cumulative effective dose and changing trends over 2 decades","volume":"141","author":"McWilliams","year":"2012","journal-title":"Chest"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Silva, I.A.L., Laselva, O., and Lopes-Pacheco, M. (2022). Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis. J. Pers. Med., 12.","DOI":"10.3390\/jpm12081321"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene: Chromosome walking and jumping","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: Genetic analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","article-title":"Role of CFTR in epithelial physiology","volume":"74","author":"Gray","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_12","first-page":"1662","article-title":"CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine","volume":"10","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/17460441.2021.1912732","article-title":"Discovery of CFTR modulators for the treatment of cystic fibrosis","volume":"16","author":"Pedemonte","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_14","first-page":"275","article-title":"CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis","volume":"7","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2147\/JEP.S255377","article-title":"Pharmacological Modulation of Ion Channels for the Treatment of Cystic Fibrosis","volume":"13","author":"Pinto","year":"2021","journal-title":"J. Exp. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.00228013","article-title":"CFTR: Cystic fibrosis and beyond","volume":"44","author":"Mall","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic Fibrosis: A Review","volume":"329","author":"Ong","year":"2023","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/thoraxjnl-2013-204176","article-title":"Is chest CT useful in newborn screened infants with cystic fibrosis at 1 year of age?","volume":"69","author":"Thia","year":"2014","journal-title":"Thorax"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: A global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del","volume":"377","author":"Munck","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: A double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"ref_23","unstructured":"European Medicines Agency (2023, December 11). Ivacaftor EMA Summary of Product Characteristics, Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kalydeco-epar-product-information_en.pdf."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nbt0312-201a","article-title":"Cystic fibrosis drug Vertex\u2019s latest triumph","volume":"30","author":"Ledford","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201301-0153OC","article-title":"Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation","volume":"187","author":"Davies","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(15)00545-7","article-title":"Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): An open-label, single-arm study","volume":"4","author":"Davies","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.chest.2017.10.005","article-title":"CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores after CFTR Modulation with Ivacaftor","volume":"153","author":"Ronan","year":"2018","journal-title":"Chest"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(17)30215-1","article-title":"Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: A randomised, placebo-controlled phase 3 trial","volume":"5","author":"Ratjen","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1164\/rccm.201704-0717OC","article-title":"Tezacaftor\/Ivacaftor in Subjects with Cystic Fibrosis and F508del\/F508del-CFTR or F508del\/G551D-CFTR","volume":"197","author":"Donaldson","year":"2018","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"ref_31","unstructured":"Food and Drug Administration Administration (2023, December 11). Lumacaftor-ivacaftor FDA Drug Label, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/206038s016lbl.pdf."},{"key":"ref_32","unstructured":"Food and Drug Administration Administration (2023, December 11). Tezacaftor-ivacaftor FDA Drug Label, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/210491s011lbl.pdf."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Bacalhau, M., Camargo, M., Magalhaes-Ghiotto, G.A.V., Drumond, S., Castelletti, C.H.M., and Lopes-Pacheco, M. (2023). Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis. Pharmaceuticals, 16.","DOI":"10.3390\/ph16030410"},{"key":"ref_35","unstructured":"Food and Drug Administration Administration (2023, December 11). Elexacaftor-Tezacaftor-Ivacaftor FDA Drug Label, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/217660s000lbl.pdf."},{"key":"ref_36","unstructured":"Medicines and Healthcare Products Regulatory Agency (2023, December 11). Elexacaftor-Tezacaftor-Ivacaftor MHRA Summary of Product Characteristics, Available online: https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/54f21d4e55ab2249ea23dd405af50eb8b76b5b8d."},{"key":"ref_37","unstructured":"European Medicines Agency (2023, December 11). Elexacaftor-Tezacaftor-Ivacaftor EMA Summary of Product Characteristics, Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kaftrio-epar-product-information_en.pdf."},{"key":"ref_38","unstructured":"Medicines and Healthcare Products Regulatory Agency (2023, December 11). Ivacaftor MHRA Summary of Product Characteristics, Available online: https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/de94c1a13ce5d0f3d7dac0b0dc6102d26b2d376e."},{"key":"ref_39","unstructured":"Food and Drug Administration Administration (2023, December 11). Ivacaftor FDA Drug Label, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/203188s038lbl.pdf."},{"key":"ref_40","unstructured":"European Medicines Agency (2023, December 11). Lumacaftor-Ivacaftor EMA Summary of Product Characteristics, Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/orkambi-epar-product-information_en.pdf."},{"key":"ref_41","unstructured":"Medicines and Healthcare Products Regulatory Agency (2023, December 11). Lumacaftor-Ivacaftor MHRA Summary of Product Characteristics, Available online: https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/45ef55c039909cb939b92e95a6c58654cfd42834."},{"key":"ref_42","unstructured":"European Medicines Agency (2023, December 11). Tezacaftor-Ivacaftor EMA Summary of Product Characteristics, Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/symkevi-epar-product-information_en.pdf."},{"key":"ref_43","unstructured":"Medicines and Healthcare Products Regulatory Agency (2023, December 11). Tezacaftor-Ivacaftor MHRA Summary of Product Characteristics, Available online: https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/c9ab16f7d588f0647f3d026352f92a6b67527417."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09031936.00166412","article-title":"Factors associated with FEV1 decline in cystic fibrosis: Analysis of the ECFS patient registry","volume":"43","author":"Kerem","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/apa.15155","article-title":"Cystic fibrosis in the year 2020: A disease with a new face","volume":"109","year":"2020","journal-title":"Acta Paediatr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2214\/ajr.163.3.8079843","article-title":"Radiographic changes in acute exacerbations of cystic fibrosis in adults: A pilot study","volume":"163","author":"Greene","year":"1994","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1753465816680573","article-title":"Best practices in the treatment of early cystic fibrosis lung disease","volume":"11","author":"Proesmans","year":"2017","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/ppul.10280","article-title":"Correlation of six different cystic fibrosis chest radiograph scoring systems with clinical parameters","volume":"35","author":"Truijens","year":"2003","journal-title":"Pediatr. Pulmonol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcf.2019.08.005","article-title":"The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease","volume":"19","author":"Bortoluzzi","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcf.2019.04.016","article-title":"Deep learning to automate Brasfield chest radiographic scoring for cystic fibrosis","volume":"19","author":"Zucker","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1002\/ppul.24931","article-title":"Novel imaging techniques for cystic fibrosis lung disease","volume":"56","author":"Goralski","year":"2021","journal-title":"Pediatr. Pulmonol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"100263","DOI":"10.1016\/j.ejro.2020.100263","article-title":"Projected lung areas using dynamic X-ray (DXR)","volume":"7","author":"Hino","year":"2020","journal-title":"Eur. J. Radiol. Open"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejrad.2019.01.034","article-title":"Time-resolved quantitative evaluation of diaphragmatic motion during forced breathing in a health screening cohort in a standing position: Dynamic chest phrenicography","volume":"113","author":"Hida","year":"2019","journal-title":"Eur. J. Radiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcf.2022.01.007","article-title":"Measuring the effect of elexacaftor\/tezacaftor\/ivacaftor combination therapy on the respiratory pump in people with CF using dynamic chest radiography","volume":"21","author":"FitzMaurice","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1164\/rccm.200412-1665OC","article-title":"High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis","volume":"172","author":"Llapur","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/thoraxjnl-2011-200912","article-title":"Progression of early structural lung disease in young children with cystic fibrosis assessed using CT","volume":"67","author":"Mott","year":"2012","journal-title":"Thorax"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1183\/09031936.03.00006603","article-title":"Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis","volume":"23","author":"Nakano","year":"2004","journal-title":"Eur. Respir. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.201011-1892OC","article-title":"Infection, inflammation, and lung function decline in infants with cystic fibrosis","volume":"184","author":"Pillarisetti","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/thx.2007.077784","article-title":"Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis","volume":"63","author":"Gustafsson","year":"2008","journal-title":"Thorax"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1901694","DOI":"10.1183\/13993003.01694-2019","article-title":"Early markers of cystic fibrosis structural lung disease: Follow-up of the ACFBAL cohort","volume":"55","author":"Wijker","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/MCP.0000000000000732","article-title":"Monitoring early stage lung disease in cystic fibrosis","volume":"26","author":"Nissenbaum","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2214\/AJR.07.3000","article-title":"Predictive value of chest CT in patients with cystic fibrosis: A single-center 10-year experience","volume":"190","author":"Cademartiri","year":"2008","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpeds.2004.02.038","article-title":"High-resolution computed tomography in young patients with cystic fibrosis: Distribution of abnormalities and correlation with pulmonary function tests","volume":"145","author":"Brody","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1164\/rccm.201105-0816OC","article-title":"Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis","volume":"184","author":"Sanders","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1164\/rccm.201111-2065OC","article-title":"Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation","volume":"185","author":"Loeve","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.179.3.2027992","article-title":"Cystic fibrosis: Scoring system with thin-section CT","volume":"179","author":"Bhalla","year":"1991","journal-title":"Radiology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1164\/rccm.201501-0061OC","article-title":"PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis","volume":"191","author":"Rosenow","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1147348","DOI":"10.3389\/fphar.2023.1147348","article-title":"The effect of CFTR modulators on structural lung disease in cystic fibrosis","volume":"14","author":"Mok","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2100844","DOI":"10.1183\/13993003.00844-2021","article-title":"Artificial intelligence in computed tomography for quantifying lung changes in the era of CFTR modulators","volume":"59","author":"Dournes","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1148\/radiol.2017170062","article-title":"Integrated Diagnostics: The Computational Revolution Catalyzing Cross-disciplinary Practices in Radiology, Pathology, and Genomics","volume":"285","author":"Lundstrom","year":"2017","journal-title":"Radiology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1118\/1.4963214","article-title":"Automatic airway-artery analysis on lung CT to quantify airway wall thickening and bronchiectasis","volume":"43","author":"Kuo","year":"2016","journal-title":"Med. Phys."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s00247-021-05146-0","article-title":"Current and emerging artificial intelligence applications in chest imaging: A pediatric perspective","volume":"52","author":"Schalekamp","year":"2022","journal-title":"Pediatr. Radiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/MCP.0000000000000828","article-title":"The evolving role of radiological imaging in cystic fibrosis","volume":"27","author":"Crowley","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4329\/wjr.v8.i4.331","article-title":"Computed tomography dose optimisation in cystic fibrosis: A review","volume":"8","author":"Ferris","year":"2016","journal-title":"World J. Radiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00330-012-2452-z","article-title":"Model-based iterative reconstruction technique for radiation dose reduction in chest CT: Comparison with the adaptive statistical iterative reconstruction technique","volume":"22","author":"Katsura","year":"2012","journal-title":"Eur. Radiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00247-012-2554-4","article-title":"Model-based iterative reconstruction in pediatric chest CT: Assessment of image quality in a prospective study of children with cystic fibrosis","volume":"43","author":"Berteloot","year":"2013","journal-title":"Pediatr. Radiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00330-012-2627-7","article-title":"Computed tomography of the chest with model-based iterative reconstruction using a radiation exposure similar to chest X-ray examination: Preliminary observations","volume":"23","author":"Neroladaki","year":"2013","journal-title":"Eur. Radiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1148\/radiol.2532090306","article-title":"Cystic fibrosis: Are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease?","volume":"253","author":"Loeve","year":"2009","journal-title":"Radiology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2214\/ajr.170.5.9574614","article-title":"Air trapping on expiratory high-resolution CT scans in the absence of inspiratory scan abnormalities: Correlation with pulmonary function tests and differential diagnosis","volume":"170","author":"Arakawa","year":"1998","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.prrv.2006.04.002","article-title":"Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis","volume":"7","author":"Tiddens","year":"2006","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.acra.2023.05.029","article-title":"Photon Counting CT: Technical Principles, Clinical Applications, and Future Prospects","volume":"30","author":"Wu","year":"2023","journal-title":"Acad. Radiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1148\/radiol.2018172656","article-title":"Photon-counting CT: Technical Principles and Clinical Prospects","volume":"289","author":"Willemink","year":"2018","journal-title":"Radiology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1378\/chest.07-0221","article-title":"Estimation of the radiation dose from thoracic CT scans in a cystic fibrosis population","volume":"132","author":"Donadieu","year":"2007","journal-title":"Chest"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00247-020-04706-0","article-title":"Computed tomography in cystic fibrosis lung disease: A focus on radiation exposure","volume":"51","author":"Joyce","year":"2021","journal-title":"Pediatr. Radiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcf.2019.09.001","article-title":"Guidance for computed tomography (CT) imaging of the lungs for patients with cystic fibrosis (CF) in research studies","volume":"19","author":"Brody","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcf.2023.06.006","article-title":"Replacing Plain Radiograph with ultra-low dose CT thorax in cystic fibrosis (CF) in the era of CFTR modulation and its impact on cumulative effective dose","volume":"22","author":"Sheahan","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/mrm.26891","article-title":"A double echo ultra short echo time (UTE) acquisition for respiratory motion-suppressed high resolution imaging of the lung","volume":"79","author":"Delacoste","year":"2018","journal-title":"Magn. Reson. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1007\/s00330-016-4218-5","article-title":"Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution","volume":"26","author":"Dournes","year":"2016","journal-title":"Eur. Radiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1513\/AnnalsATS.201603-203OC","article-title":"Ultrashort Echo-Time Magnetic Resonance Imaging Is a Sensitive Method for the Evaluation of Early Cystic Fibrosis Lung Disease","volume":"13","author":"Roach","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jcf.2018.05.003","article-title":"Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosis","volume":"17","author":"Stahl","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1164\/rccm.202102-0278OC","article-title":"Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis","volume":"204","author":"Stahl","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.acra.2021.01.007","article-title":"Comparison of Hyperpolarized (3)He and (129)Xe MR Imaging in Cystic Fibrosis Patients","volume":"29","author":"Shammi","year":"2022","journal-title":"Acad. Radiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"20170647","DOI":"10.1259\/bjr.20170647","article-title":"Hyperpolarized gas MRI in pulmonology","volume":"91","author":"Kern","year":"2018","journal-title":"Br. J. Radiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1148\/radiol.2019182391","article-title":"Hyperpolarized (13)C MRI: State of the Art and Future Directions","volume":"291","author":"Wang","year":"2019","journal-title":"Radiology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/mrm.20051","article-title":"Assessment of human pulmonary function using oxygen-enhanced T(1) imaging in patients with cystic fibrosis","volume":"51","author":"Jakob","year":"2004","journal-title":"Magn. Reson. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejrad.2007.08.006","article-title":"Basics concepts and clinical applications of oxygen-enhanced MR imaging","volume":"64","author":"Ohno","year":"2007","journal-title":"Eur. J. Radiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00247-020-04638-9","article-title":"Lung T1 mapping magnetic resonance imaging in the assessment of pulmonary disease in children with cystic fibrosis: A pilot study","volume":"50","author":"Neemuchwala","year":"2020","journal-title":"Pediatr. Radiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/j.jcf.2021.11.006","article-title":"Magnetic resonance imaging of cystic fibrosis: Multi-organ imaging in the age of CFTR modulator therapies","volume":"21","author":"McBennett","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e230084","DOI":"10.1148\/radiol.230084","article-title":"Lung Function in Patients with Cystic Fibrosis before and during CFTR-Modulator Therapy Using 3D Ultrashort Echo Time MRI","volume":"308","author":"Heidenreich","year":"2023","journal-title":"Radiology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jcf.2018.02.003","article-title":"Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis","volume":"17","author":"Wagener","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jcf.2022.12.012","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy in children with cystic fibrosis\u2014A comprehensive assessment using lung clearance index, spirometry, and functional and structural lung MRI","volume":"22","author":"Streibel","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/(SICI)1522-2586(199903)9:3<483::AID-JMRI18>3.0.CO;2-#","article-title":"MR perfusion imaging of pulmonary parenchyma using pulsed arterial spin labeling techniques: FAIRER and FAIR","volume":"9","author":"Mai","year":"1999","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.202201-0219OC","article-title":"Effects of Elexacaftor\/Tezacaftor\/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles","volume":"206","author":"Graeber","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"107328","DOI":"10.1016\/j.rmed.2023.107328","article-title":"Structural changes in lung morphology detected by MRI after modulating therapy with elexacaftor\/tezacaftor\/ivacaftor in adolescent and adult patients with cystic fibrosis","volume":"216","author":"Fainardi","year":"2023","journal-title":"Respir. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcf.2020.06.006","article-title":"The Emergence of Elastography for Cystic Fibrosis Liver Disease","volume":"19","author":"Masand","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00261-018-1750-6","article-title":"Application of BOLD-MRI in the classification of renal function in chronic kidney disease","volume":"44","author":"Li","year":"2019","journal-title":"Abdom. Radiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11897-015-0261-9","article-title":"Role of Imaging Techniques for Diagnosis, Prognosis and Management of Heart Failure Patients: Cardiac Magnetic Resonance","volume":"12","author":"Gonzalez","year":"2015","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1259\/bjr\/24009651","article-title":"MRI appearance of the pancreas in patients with cystic fibrosis: A comparison of pancreas volume in diabetic and non-diabetic patients","volume":"83","author":"Sequeiros","year":"2010","journal-title":"Br. J. Radiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1378\/chest.09-0610","article-title":"18F-fluorodeoxyglucose-PET\/CT imaging of lungs in patients with cystic fibrosis","volume":"136","author":"Klein","year":"2009","journal-title":"Chest"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1148\/radiol.12111873","article-title":"Cystic fibrosis: Detecting changes in airway inflammation with FDG PET\/CT","volume":"264","author":"Amin","year":"2012","journal-title":"Radiology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40658-023-00605-z","article-title":"Reducing pediatric total-body PET\/CT imaging scan time with multimodal artificial intelligence technology","volume":"11","author":"Zhang","year":"2024","journal-title":"EJNMMI Phys."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Sansone, F., Attanasi, M., Di Filippo, P., Sferrazza Papa, G.F., Di Pillo, S., and Chiarelli, F. (2021). Usefulness of Lung Ultrasound in Paediatric Respiratory Diseases. Diagnostics, 11.","DOI":"10.3390\/diagnostics11101783"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ppul.26787","article-title":"Lung ultrasound evaluation in people with cystic fibrosis: A new approach in the pulmonology outpatient clinic","volume":"59","author":"Curatola","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00134-012-2513-4","article-title":"International evidence-based recommendations for point-of-care lung ultrasound","volume":"38","author":"Volpicelli","year":"2012","journal-title":"Intensive Care Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4187\/respcare.07038","article-title":"The Use of Ultrasound as a Tool to Evaluate Pulmonary Disease in Cystic Fibrosis","volume":"65","author":"Peixoto","year":"2020","journal-title":"Respir. Care"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Strzelczuk-Judka, L., Wojsyk-Banaszak, I., Zakrzewska, A., and Jonczyk-Potoczna, K. (2019). Diagnostic value of chest ultrasound in children with cystic fibrosis\u2014Pilot study. PLoS ONE, 14.","DOI":"10.1101\/604942"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s10995-016-2181-z","article-title":"Attitudes and Decision Making Related to Pregnancy among Young Women with Cystic Fibrosis","volume":"21","author":"Kazmerski","year":"2017","journal-title":"Matern. Child Health J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcf.2020.12.011","article-title":"Elexacafator\/tezacaftor\/ivacaftor resolves subfertility in females with CF: A two center case series","volume":"20","author":"Goodwin","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jcf.2021.12.004","article-title":"Drug exposure to infants born to mothers taking Elexacaftor, Tezacaftor, and Ivacaftor","volume":"21","author":"Collins","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1148\/radiology.204.1.9205213","article-title":"Cystic fibrosis: 1997","volume":"204","author":"Wood","year":"1997","journal-title":"Radiology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/ppul.20718","article-title":"Early intervention in CF: How to monitor the effect","volume":"42","author":"Weiser","year":"2007","journal-title":"Pediatr. Pulmonol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"102239","DOI":"10.1016\/j.coph.2022.102239","article-title":"Current state of CFTR modulators for treatment of Cystic Fibrosis","volume":"65","author":"Despotes","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/joim.12399","article-title":"Exome and genome sequencing: A revolution for the discovery and diagnosis of monogenic disorders","volume":"279","author":"Stranneheim","year":"2016","journal-title":"J. Intern. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.semcancer.2020.09.009","article-title":"Ethical challenges of precision cancer medicine","volume":"84","author":"Winkler","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2022.09.005","article-title":"Access and quality of biomarker testing for precision oncology in Europe","volume":"176","author":"Normanno","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.semcancer.2021.05.026","article-title":"Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany","volume":"84","author":"Stenzinger","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1156621","DOI":"10.3389\/fphar.2023.1156621","article-title":"Individualized approach to elexacaftor\/tezacaftor\/ivacaftor dosing in cystic fibrosis, in response to self-reported anxiety and neurocognitive adverse events: A case series","volume":"14","author":"Ibrahim","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/phar.2786","article-title":"Safety of elexacaftor\/tezacaftor\/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series","volume":"43","author":"Hong","year":"2023","journal-title":"Pharmacotherapy"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jcf.2022.05.001","article-title":"Dose adjustments of Elexacaftor\/Tezacaftor\/Ivacaftor in response to mental health side effects in adults with cystic fibrosis","volume":"21","author":"Spoletini","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/ppul.23266","article-title":"Respiratory tract exacerbations revisited: Ventilation, inflammation, perfusion, and structure (VIPS) monitoring to redefine treatment","volume":"50","author":"Tiddens","year":"2015","journal-title":"Pediatr. Pulmonol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ppul.21374","article-title":"Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis","volume":"46","author":"Sanders","year":"2011","journal-title":"Pediatr. Pulmonol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"393.e9","DOI":"10.1016\/j.crad.2020.12.003","article-title":"Ultra-low-dose thoracic CT with model-based iterative reconstruction (MBIR) in cystic fibrosis patients undergoing treatment with cystic fibrosis transmembrane conductance regulators (CFTR)","volume":"76","author":"Moloney","year":"2021","journal-title":"Clin. Radiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: A 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jped.2018.07.010","article-title":"Ultra-low-dose chest computed tomography without anesthesia in the assessment of pediatric pulmonary diseases","volume":"96","author":"Dorneles","year":"2020","journal-title":"J. Pediatr."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/HP.0000000000000022","article-title":"Dose tracking and rational examination selection for the medically-exposed population","volume":"106","author":"Brink","year":"2014","journal-title":"Health Phys."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"858","DOI":"10.2214\/AJR.12.10233","article-title":"Continuous monitoring of CT dose indexes at Dubai Hospital","volume":"201","author":"AlSuwaidi","year":"2013","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jacr.2017.08.014","article-title":"An Assessment of the Quality of CT Radiation Dose Information on the Internet","volume":"15","author":"Glynn","year":"2018","journal-title":"J. Am. Coll. Radiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcf.2014.03.009","article-title":"European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre","volume":"13","author":"Conway","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Southern, K., Addy, C., Bell, S., Bevan, A., Borawska, U., Brown, C., Burgel, P.R., Button, B., Castellani, C., and Chansard, A. (J. Cyst. Fibros., 2023). Standards for the care of people with cystic fibrosis; establishing and maintaining health, J. Cyst. Fibros., in press.","DOI":"10.1016\/j.jcf.2023.12.002"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thoraxjnl-2017-210473","article-title":"The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers","volume":"73","author":"Rowbotham","year":"2018","journal-title":"Thorax"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/thoraxjnl-2020-216085","article-title":"Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis","volume":"76","author":"Bayfield","year":"2021","journal-title":"Thorax"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"210173","DOI":"10.1183\/16000617.0173-2021","article-title":"State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the \u201ciMAging managEment of cySTic fibROsis\u201d (MAESTRO) consortium","volume":"31","author":"Ciet","year":"2022","journal-title":"Eur. Respir. Rev."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/11\/2\/256\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:00:56Z","timestamp":1760104856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/11\/2\/256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":143,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["children11020256"],"URL":"https:\/\/doi.org\/10.3390\/children11020256","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]}}}